Guided Therapeutics (GTHP) Notes Payables (2011 - 2025)
Guided Therapeutics recorded quarterly Notes Payables of $105000.0 in Q4 2025, down 74.45% quarter-over-quarter from $411000.0 in Q3 2025, and down 24.46% year-over-year from $139000.0 in Q4 2024.
Guided Therapeutics' Notes Payables history runs 15 years deep, the most recent figure standing at $105000.0 for Q4 2025.
- In Q4 2025, Notes Payables fell 24.46% year-over-year to $105000.0; the TTM figure through Dec 2025 stood at $105000.0 (down 24.46% YoY), while the FY2025 annual figure was $105000.0, down 24.46% from the prior year.
- Notes Payables came in at $105000.0 for Q4 2025 at Guided Therapeutics, down from $411000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $421000.0 in Q2 2025 to a low of $11000.0 in Q1 2021.
- A 5-year average of $109558.9 and a median of $59000.0 in 2023 frame the typical range for Notes Payables.
- Across the five-year window, Notes Payables sank 98.51% in 2021 and surged 452.94% in 2023, its largest moves.
- Guided Therapeutics' Notes Payables stood at $48000.0 in 2021, then gained by 17.85% to $56569.0 in 2022, then rose by 4.3% to $59000.0 in 2023, then soared by 135.59% to $139000.0 in 2024, then dropped by 24.46% to $105000.0 in 2025.
- According to Business Quant data, Notes Payables over the past three periods registered $105000.0, $411000.0, and $421000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 105,000.00 |
| Sep 30, 2025 | 411,000.00 |
| Jun 30, 2025 | 421,000.00 |
| Mar 31, 2025 | 48,000.00 |
| Dec 31, 2024 | 139,000.00 |
| Sep 30, 2024 | 228,000.00 |
| Jun 30, 2024 | 83,162.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Sep 30, 2023 | 94,000.00 |
| Mar 31, 2023 | 22,770.00 |
| Dec 31, 2022 | 56,569.00 |
| Sep 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 12,000.00 |
| Dec 31, 2021 | 48,000.00 |
| Sep 30, 2021 | 83,000.00 |
| Mar 31, 2021 | 11,000.00 |
| Sep 30, 2020 | 261,000.00 |
| Jun 30, 2020 | 432,000.00 |
| Mar 31, 2020 | 740,000.00 |
| Dec 31, 2019 | 2.92 Mn |
| Sep 30, 2019 | 97,000.00 |
| Jun 30, 2019 | 313,000.00 |
| Mar 31, 2019 | 2.82 Mn |
| Dec 31, 2018 | 2.78 Mn |
| Sep 30, 2018 | 2.35 Mn |
| Jun 30, 2018 | 2.35 Mn |
| Mar 31, 2018 | 905,000.00 |
| Dec 31, 2017 | 2.32 Mn |
| Sep 30, 2017 | 2.32 Mn |
| Jun 30, 2017 | 2.67 Mn |
| Mar 31, 2017 | 2.35 Mn |
| Dec 31, 2016 | 2.36 Mn |
| Sep 30, 2016 | 517,000.00 |
| Jun 30, 2016 | 602,000.00 |
| Mar 31, 2016 | 479,000.00 |
| Dec 31, 2015 | 686,000.00 |
| Sep 30, 2015 | 935,000.00 |
| Mar 31, 2015 | 168,000.00 |
| Dec 31, 2014 | 123,000.00 |
| Sep 30, 2014 | 564,000.00 |
| Jun 30, 2014 | 282,000.00 |
| Mar 31, 2014 | 201,000.00 |
| Dec 31, 2013 | 109,000.00 |
| Sep 30, 2013 | 233,000.00 |
| Jun 30, 2013 | 101,000.00 |
| Mar 31, 2013 | 283,000.00 |
| Dec 31, 2012 | 4,000.00 |
| Sep 30, 2012 | 406,000.00 |
| Jun 30, 2012 | 393,000.00 |
| Mar 31, 2012 | 24,000.00 |
| Dec 31, 2011 | 25,000.00 |
| Sep 30, 2011 | 353,000.00 |
| Jun 30, 2011 | 340,000.00 |